Projects per year
Personal profile
Education/Academic qualification
Pharmacy, Research Fellowship, Department of Clinical Sciences and Administration, College of Pharmacy, University of Houston
Award Date: Jun 30 2011
Pharmacy, Clinical Fellowship, St. Luke's Episcopal Hospital
Award Date: Jun 30 2010
Pharmacy, Residency, University of Texas Medical Branch
Award Date: Jun 30 2009
Pharmacy, PharmD, Department of Clinical Sciences and Administration, College of Pharmacy, University of Houston
Award Date: May 11 2008
External positions
Associate Professor of Pharmacology Research in Medicine, Weill Cornell Medical College
Apr 1 2023 → …
Adjunct Assistant Professor, Universidad El Bosque
Jan 1 2015 → …
Research Area Keywords
- Infectious Disease & Pathology
Free-text keywords
- Enterococcus
- Daptomycin resistance
- Antimicrobial resistance
Fingerprint
Dive into the research topics where Cecilia Tran is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
SNAP - Staphylococcus aureus Network Adaptive Platform trial
Arias, C. A. (PI), Miller, W. R. (Key Personnel) & Tran, C. (Key Personnel)
Project: Clinical Trial
-
Defining Evolutionary Trajectories: Molecular adaptation to antibiotic resistance
Tran, C. (PI)
4/1/22 → 3/31/24
Project: Federal Funding Agencies
-
Cefiderocol heteroresistance associated with mutations in TonB-dependent receptor genes in Pseudomonas aeruginosa of clinical origin.
Egge, S. L., Rizvi, S. A., Simar, S. R., Alcalde, M., Martinez, J. R. W., Hanson, B. M., Dinh, A. Q., Baptista, R. P., Tran, T. T., Shelburne, S. A., Munita, J. M., Arias, C. A., Hakki, M. & Miller, W. R., Jul 12 2024, In: Antimicrobial Agents and Chemotherapy. p. e0012724Research output: Contribution to journal › Article › peer-review
-
Clinical Features and Genomic Epidemiology of Bloodstream Infections due to Enterococcal Species Other Than Enterococcus faecalis or E. faecium in Patients With Cancer
Axell-House, D. B., Ashley, P. A., Egge, S. L., Tran, T. T., Pedroza, C., Zhang, M., Dinh, A. Q., Simar, S. R., Sahasrabhojane, P. V., Miller, W. R., Shelburne, S. A., Hanson, B. M. & Arias, C. A., Jun 1 2024, In: Open Forum Infectious Diseases. 11, 6Research output: Contribution to journal › Article › peer-review
Open Access -
Differential in vitro susceptibility to ampicillin/ceftriaxone combination therapy among Enterococcus faecalis infective endocarditis clinical isolates
Westbrook, K. J., Chilambi, G. S., Stellfox, M. E., Nordstrom, H. R., Li, Y., Iovleva, A., Shah, N. H., Jones, C. E., Kline, E. G., Squires, K. M., Miller, W. R., Tran, T. T., Arias, C. A., Doi, Y., Shields, R. K. & Tyne, D. V., Apr 1 2024, In: Journal of Antimicrobial Chemotherapy. 79, 4, p. 801-809 9 p.Research output: Contribution to journal › Article › peer-review
-
LiaX is a surrogate marker for cell envelope stress and daptomycin non-susceptibility in Enterococcus faecium
Axell-House, D. B., Simar, S. R., Panesso, D., Rincon, S., Miller, W. R., Khan, A., Pemberton, O. A., Valdez, L., Nguyen, A. H., Hood, K. S., Rydell, K., DeTranaltes, A. M., Jones, M. N., Atterstrom, R., Reyes, J., Sahasrabhojane, P. V., Suleyman, G., Zervos, M., Shelburne, S. & Singh, K. V. & 4 others, , Mar 2024, In: Antimicrobial Agents and Chemotherapy. 68, 3Research output: Contribution to journal › Article › peer-review
Open Access -
Re lower (1,3)-beta-D-glucan sensitivity and in vitro levels in Candida auris and Candida parapsilosis strains by Mikulska et al.
Adelman, M. W., Tran, T. T. & Shukla, B., May 21 2024, (E-pub ahead of print) In: Clinical Microbiology and Infection.Research output: Contribution to journal › Letter › peer-review
1 Scopus citations